Up 57% this year. Guess which ASX 200 stock just hit a multi-year high?

A huge turnaround has pushed this ASX healthcare stock to fresh highs.

At the start of 2026, Ramsay Health Care Ltd (ASX: RHC) was hardly the kind of stock investors were chasing.

Fast-forward 8 months, and the picture looks very different.

Ramsay shares are up another 1.52% to $54.11 on Thursday, taking the private hospital operator to its highest level in several years.

The stock has now surged around 57% in 2026 and sits almost 80% above its 52-week low of $30.39.

It was changing hands at just $44.02 on 26 August. Since then, the share price has jumped almost 23% in a little over 2 weeks.

After years of going nowhere, Ramsay has suddenly become one of the more interesting turnaround stories on the ASX.

And I think its latest results explain a lot of the recent excitement.

A kid and his grandad high five after a fun game of basketball.

Image source: Getty Images

The numbers are finally improving

Ramsay's FY26 result was a pretty decent one.

Revenue came in at $18.6 billion, while underlying EBIT rose 11.8% to around $1.16 billion.

Underlying net profit after tax (NPAT) increased 19.3% to $364.1 million, or 22.9% on a constant currency basis.

Australia did much of the work, helped by higher hospital activity, better theatre utilisation, improved private health insurance pricing, and tighter cost control.

The group's underlying EBIT margin also improved by 30 basis points to 6.2%.

Shareholders got a little extra too, with the full-year dividend rising 13.8% to 91 cents per share.

The business could look very different

Ramsay is moving ahead with plans to separate its 52.79% stake in Ramsay Santé, which owns hospitals across Europe.

Shareholders are expected to vote on the proposed demerger in November.

If the deal goes ahead, investors would be left with a simpler Ramsay business and a much clearer view of how its Australian hospitals are performing.

Ramsay is still putting money into Australia too, with the company agreeing to buy National Capital Private Hospital in Canberra for $251 million.

Management expects the acquisition to add to earnings in its first 12 months.

Would I buy Ramsay shares?

This is probably where I would be a little more careful.

At $54.11, Ramsay shares have already moved above the average TipRanks analyst price target of $50.66. The highest target is $55.69.

Director Michael Siddle also sold 1 million shares at $49 shortly after the result, in an off-market transaction worth $49 million.

Yes, I still like what I am seeing from the business, and I think the turnaround has more substance behind it.

But I wouldn't be chasing Ramsay shares purely because they have been going up.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

Smiling woman holding Australian dollar notes in each hand, symbolising dividends.
Opinions

Why I'd buy this ASX share over a term deposit

A few ASX shares can provide resilience, dividends, and growth.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Opinions

2 ASX shares where broker forecasts caught my attention

These two ASX shares deserve a closer look.

Read more »

Woman with her hands out to each side on a light blue background.
Opinions

I compared dividends, earnings, and growth across the ASX: These 3 shares stood out

These ASX shares caught my attention. Here’s why.

Read more »

A businessman holding a butterfly net looks around hoping to snare a good ASX share investment.
Opinions

I hunted the ASX for oversold shares. These 3 stood out

These ASX shares look oversold and under priced to me.

Read more »

Family smile and laugh as they look at a laptop.
Opinions

I've been looking for long-term ASX investments for my kids. These 4 made my shortlist

When I'm investing for my kids' futures, these are the criteria I'm looking for.

Read more »

A young woman sits with her hand to her chin staring off to the side thinking about her investments.
Opinions

CSL shares: I weighed up the bull and bear case, and here's my final verdict

The ASX biotech company has rebounded strongly from a multi-year low in June.

Read more »

A young woman sitting in a classroom smiles as she ponders lessons learned.
Opinions

I looked at the bear case for these 3 ASX shares, and came to a different conclusion. Here's why

Here’s my take on these three ASX shares.

Read more »

Broom sweeping cash into dust pan.
Opinions

Up 20%: Has the EQT deal saved Cleanaway shares?

Cleanaway's 20% jump takes it back to 2022 prices.

Read more »